Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2003
09/18/2003WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
09/18/2003WO2003024472A3 Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof
09/18/2003WO2003024419A3 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
09/18/2003WO2003023013A3 Novel nucleic acids and polypeptides
09/18/2003WO2003018782A3 Differentiation of neural stem cells and therapeutic use theeof
09/18/2003WO2003008441A3 Moringa seed proteins
09/18/2003WO2003005941A3 Insert for the treatment of dry eye
09/18/2003WO2003004628A3 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme
09/18/2003WO2002103015A3 Abca10 transporter
09/18/2003WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
09/18/2003WO2002094868A3 Staphylococcus aureus proteins and nucleic acids
09/18/2003WO2002083184A3 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
09/18/2003WO2002080982A3 Nucleic acid mucosal immunization
09/18/2003WO2002077174A3 Human cytokine receptor
09/18/2003WO2002068455A3 Efficient recovery of correctly refolded proteins
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002064793A3 G protein-coupled receptor-like proteins and nucleics acids encoding same
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002057458A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/18/2003WO2002053177A3 Agents and methods for treating pain
09/18/2003WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease
09/18/2003WO2002048328A9 Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof
09/18/2003WO2002036810A3 Antisense modulation of talin expression
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003WO2002017950A8 Detecting and influencing the expression or function of cd95/cd95l in infections
09/18/2003WO2002007757A3 Prevention and treatment of sexual arousal disorders
09/18/2003WO2002000687A9 Antimicrobial peptides and methods of use thereof
09/18/2003WO2001072956A3 Compounds and methods for modulating desmosomal cadherin-mediated functions
09/18/2003US20030177513 Insertion genome; activation; generating embryo
09/18/2003US20030177511 Antitumor, anticancer agents
09/18/2003US20030176853 Sustained release delivery systems for solutes
09/18/2003US20030176689 Inhibitors of hepatitis C virus protease
09/18/2003US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176683 Bone repair; animal extract in matrix
09/18/2003US20030176681 Antiarthritic agents; autoimmune diseases; antihistamines; Aids; psoriasis
09/18/2003US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna
09/18/2003US20030176676 Methods of treating vascular inflammatory pathologies using chimeric anti-TNF antibodies
09/18/2003US20030176672 Compositions and methods relating to breast specific genes and proteins
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176668 C-nitroso compounds and use thereof
09/18/2003US20030176667 Transfroming growth factor; drug design
09/18/2003US20030176666 Hypothalamus-specific polypeptides
09/18/2003US20030176663 Specific binding molecules for scintigraphy
09/18/2003US20030176659 Adipocyte-specific protein homologs
09/18/2003US20030176658 Adipocyte-specific protein homologs
09/18/2003US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/18/2003US20030176652 Human and mouse beta-defensins, antimicrobial peptides
09/18/2003US20030176651 Multiprotein-complex comprising a nmda receptor and uses thereof
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176649 Genetic engineering; cardiovascular disorders; antiischemic agents; antitumor agents; vision disorders; antiarthritic agents
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030176645 Polypeptides; lubricant of mouth cavity
09/18/2003US20030176643 Which function as motilin receptor antagonists; gastrointestinal motility suppressors
09/18/2003US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
09/18/2003US20030176640 SGIP peptides
09/18/2003US20030176639 Peptide-based compounds
09/18/2003US20030176509 Methods and products related to 16-HETE analogs
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176409 Administering a low dose of estrogen to mammal
09/18/2003US20030176398 Prodrugs of GABA analogs, compositions and uses thereof
09/18/2003US20030176392 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
09/18/2003US20030176385 For modulating the expression of H-Ras, WNT-7B, acetylglucosaminyltransferase, voltage-gated K channel, IL-8, ion transport, Map3K8 and Thymidine kinase
09/18/2003US20030176384 Antisense oligonucleotides for the inhibition of integrin alphav -subunit expression
09/18/2003US20030176383 Antisense modulation of p38 mitogen activated protein kinase expression
09/18/2003US20030176380 Antisense modulation of helicase-moi expression
09/18/2003US20030176379 Useful in the administration of a drug, therapy
09/18/2003US20030176377 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
09/18/2003US20030176376 Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof
09/18/2003US20030176375 Method of treating anemia
09/18/2003US20030176374 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
09/18/2003US20030176372 Anti-virus agent
09/18/2003US20030176371 For therapy of autoimmune disorders, cancer
09/18/2003US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation
09/18/2003US20030176360 For use in drugs used for therapy of prostate cancer, benign prostatic hyperplasia, endometriosis, hysteromyoma, metrofibroma, precocious puberty, breast cancer, and the like
09/18/2003US20030176359 Administration of a thiol-based chemoprotectant compound
09/18/2003US20030176356 Endothelin antagonists and endothelin-converting enzyme inhibitors for the treatment of glaucoma
09/18/2003US20030176355 Administering protein and biologically active substance; formulation acquires a non-liquid form under physiological conditions and biologically active substance is delivered from non-liquid to localized site
09/18/2003US20030176354 Therapeutic uses of tri-, tetra-, penta-, and polypeptides
09/18/2003US20030176353 Lys-pro-val dimer, formulations and applications
09/18/2003US20030176352 Peptides and related compounds having thrombopoietic activity
09/18/2003US20030176351 Peptides and peptide analogues designed from a diabetes-associated autoantigen, and methods for their use in the treatment and prevention of diabetes
09/18/2003US20030176350 Method of inhibiting cell proliferation using an anti-oncogene protein
09/18/2003US20030176349 Stable hypoxia inducible factor-1 alpha and method of use
09/18/2003US20030176348 For use as therapeutic agent for a syndrome resembling premature aging, a therapeutic agent for adult diseases or an aging-suppressing agent
09/18/2003US20030176347 Remedies for amyotrophic lateral sclerosis
09/18/2003US20030176346 Using substances that activate the CNTF (ciliary neurotrophic factor) receptor for the preparation of pharmaceutical formulations for therapy of obesity and diseases associated therewith, for example diabetes
09/18/2003US20030176345 Wound healing composition and method for use thereof
09/18/2003US20030176343 Administering to the subject an amount of topors (protein) effective to inhibit the uncontrolled proliferation for therapy
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176340 For therapy of renal failure
09/18/2003US20030176339 For therapy and prophylaxis of diabetes, obesity, arteriosclerosis, hyperlipemia, hypertriglyceridemia, hypo-high density lipoproteinemia, hypoapolipoproteinemia A-I or nervous disorders
09/18/2003US20030176337 Useful for inhibiting microbial infection or growth, as well reducing the effects of endotoxemia
09/18/2003US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2003US20030176335 Surfactant peptide nanostructures, and uses thereof
09/18/2003US20030176334 Using vitronectin alpha v beta 3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases
09/18/2003US20030176333 Contacting the compound with a CASPR3 polypeptide, polypeptide encoded by a nucleic acid that hybridizes under stringent conditions to a nucleic acid encoding a polypeptide; determining functional effect of the compound upon the CASPR3
09/18/2003US20030176332 Novel use of cytokine inhibitors
1 ... 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 ... 3163